NYC Health News

"> ">

NYU Langone Uses AI to Improve Radiology Training

NYU Langone Health researchers have developed an artificial intelligence-based approach designed to identify gaps in radiology residents' clinical training and provide personalized teaching cases. The system tracked the types of conditions residents encountered during their regular clinical work and identified important pathologies they had seen less frequently. Researchers then used ChatGPT-4o to help select three to five supplemental cases for each resident, which appeared alongside their regular clinical work and were reviewed with supervising physicians. The study found that the AI could identify exposure gaps and recommend needed case pathologies with more than 90% accuracy. Researchers say the approach could eventually be expanded to additional radiology specialties.

"> ">

NYC-Based AFSP Awards $9.47M for Suicide Research

The New York City-based American Foundation for Suicide Prevention is awarding $9.47 million through 29 new research grants examining ways to prevent suicide and improve treatment for people at risk. The projects address subjects including suicidal behavior among adolescents, rapid responses to suicide clusters, prevention strategies for Indigenous youth and treatment approaches combining ketamine with cognitive behavioral therapy. Other research will examine suicide risk among women who have experienced interpersonal violence and the relationship between cannabis use, cognitive processing and suicide risk in young adults. AFSP says the latest awards bring its total investment in research above $100 million and approximately 900 funded grants since the organization was founded in 1987.

"> ">

New Bronx Mental Health Clubhouse Opens in Fordham

A newly constructed clubhouse has opened in the Bronx to provide free community support for New Yorkers living with serious mental illness. Venture House Bronx in Fordham Heights includes a commercial kitchen, dining area, wellness center and art and media studios, with programs designed to help members build relationships, pursue employment and education and participate in community activities. The facility is part of New York City's expanded clubhouse network for adults with conditions that can include schizophrenia, major depression and bipolar disorder. The Health Department says approximately 5,000 people are active clubhouse members citywide, with roughly half joining during the past two years. Membership is available regardless of insurance, immigration or housing status.

"> ">

Mount Sinai, J&J Partner on New Brain Tumor Treatment

Mount Sinai researchers are collaborating with Johnson & Johnson to evaluate an experimental technology designed to deliver radiation directly to brain tumors through their blood supply. Developed by clinical researchers at the Icahn School of Medicine at Mount Sinai, the approach combines Iodine-131 with Johnson & Johnson's TRUFILL n-BCA in an effort to simultaneously restrict blood flow to a tumor and concentrate radiation within targeted vessels. Initial research will focus on meningiomas, the most common primary brain tumors in adults. Researchers will use patient-derived 3D-printed vascular models and advanced imaging to study how the agent is distributed before moving to preclinical evaluation. The research could provide a foundation for potential future clinical studies.

"> ">

NYC Hospitals Complete $10M Energy-Saving Upgrades

NYC Health + Hospitals has completed nearly $10 million in energy-efficiency improvements at two public healthcare facilities in Queens and Manhattan. More than 16,000 aging light fixtures at NYC Health + Hospitals/Queens in Jamaica and NYC Health + Hospitals/Coler on Roosevelt Island were replaced with high-efficiency LED technology and modern controls. The projects are expected to save approximately 2 million kilowatt-hours of electricity and about $461,000 in energy, maintenance and related costs annually while eliminating roughly 600 metric tons of carbon emissions each year. The upgrades were funded through the Department of Citywide Administrative Services and implemented by the New York Power Authority as part of broader efforts to reduce energy consumption and emissions from municipal buildings.

"> ">

Mount Sinai Study Finds Clues to CAR-T Side Effects

Mount Sinai researchers have identified biological changes that may help explain why some multiple myeloma patients develop a serious intestinal complication following CAR-T cell therapy. The study found that CAR-T cells can remain in intestinal tissue long after treatment and that patients with CAR-T-associated enterocolitis experience widespread disruption involving several types of cells in the gut. Researchers also detected increased activity in inflammatory pathways that could provide targets for future therapies. Two patients treated with the JAK1 inhibitor upadacitinib experienced improvements in symptoms and intestinal inflammation, although further research is needed. The study, led by researchers at the Icahn School of Medicine at Mount Sinai, was published September 23 in Nature Medicine.

"> ">

$143M Queens Senior Housing Opens With 173 Homes

A $143 million affordable and supportive housing development has been completed in Jamaica, Queens, adding 173 apartments for older New Yorkers along with an on-site health center. Sutphin Senior Housing and Clinic includes 121 apartments for residents age 62 and older earning up to 50 percent of Area Median Income and 52 supportive units for people age 55 and older who have experienced chronic homelessness. All apartments receive project-based Section 8 rental assistance. The 15-story development at 97-10 Sutphin Boulevard also includes a 15,000-square-foot Community Healthcare Network health center offering medical and psychiatric care to residents and the surrounding community. The all-electric building incorporates solar power and other energy-efficiency features.

"> ">

Mount Sinai Finds New Clues to Alzheimer’s Treatment

Mount Sinai researchers have uncovered new details about how the APOE4 gene contributes to brain changes associated with Alzheimer's and other neurodegenerative diseases, identifying biological processes that could become targets for future treatments. In two studies published in Cell and Cell Stem Cell, scientists found that APOE4 can contribute to damage in cells supporting brain blood vessels while also disrupting processes involved in clearing abnormal proteins. Researchers were able to reverse some vascular changes in experimental models by blocking a specific signaling pathway. The team also used Mount Sinai's stem cell-derived miBrain platform to recreate complex human brain tissue, providing researchers with a new way to investigate disease mechanisms and potentially test therapies more efficiently.

"> ">

NYU Langone Named No. 1 U.S. Health System Again

NYU Langone Health has earned the top position in Vizient's national health system rankings for the fifth consecutive year, becoming the first system to hold the organization's No. 1 ranking for five straight years. Its Manhattan campus also ranked first among 122 comprehensive academic medical centers, while NYU Langone's network of more than 400 outpatient practices placed first among 70 participating physician networks. Other facilities across the New York region also appeared in the rankings, with NYU Langone Hospital—Long Island placing No. 3 and NYU Langone Hospital—Brooklyn reaching No. 6 in their cohort. Vizient evaluates healthcare organizations using measures including safety, mortality, effectiveness, efficiency and patient experience.